Dr. Robert Miller

Nichole Tanner is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Charleston, South Carolina. Dr. Tanner is highly rated in 11 conditions, according to our data. Her top areas of expertise are Lung Nodules, Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Endoscopy. Dr. Tanner is currently accepting new patients.

Timothy Whelan is a Pulmonary Medicine provider in Charleston, South Carolina. Dr. Whelan is highly rated in 14 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Cholesterol Pneumonia, Hypersensitivity Pneumonitis, Bone Marrow Aspiration, and Lung Transplant. Dr. Whelan is currently accepting new patients.

Patrick Flume is a Distinguished Professor of Medicine and Pediatrics at the Medical University of South Carolina. He serves as the Powers-Huggins Endowed Chair for Cystic Fibrosis and oversees a large Cystic Fibrosis (CF) Center, including the largest adult CF program in South Carolina. He also leads large clinical programs dedicated to patients with bronchiectasis and non-tuberculous mycobacterial (NTM) infections.He is recognized by the national and international CF community having served on the CF Foundation Center Committee, the Adult Care Consensus Committee, and the Advisory Task Force on Adult Issues, the Professional Education Committee, the European CF Society's Best Practices committee, and as founding co-chair of the CF Foundation's Pulmonary Practice Guidelines Committee. He co-led the International Working Group on Antimicrobial Resistance in Cystic Fibrosis. He is the Editor-in-Chief for the Journal of Cystic Fibrosis.He serves as Associate Vice President for Clinical Research at MUSC, leads a very busy clinical research program for CF, bronchiectasis, and NTM, and is co-principal investigator for the South Carolina Clinical \& Translational Research Institute. Many of these studies are related to new drug and therapy development for patients, but he also has an interest in determining optimal management of CF pulmonary exacerbations and is the co-PI in the STOP trials, aimed at identifying optimal treatments for exacerbations. Dr. Flume is highly rated in 9 conditions, according to our data. His top areas of expertise are Cystic Fibrosis, Bronchiectasis, Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex Infections, and Lung Transplant.